Watch them try to spin the overcommitment as a good thing ("omg look how much demand we have received") when all it shows is that they undervalued themselves massively and have let the soph investors and venture cap funds make out like bandits for the next 6 months while they offload their cheap shares keeping the price down once again.
- Forums
- ASX - By Stock
- Ann: FDA Approves Sofdra
Watch them try to spin the overcommitment as a good thing ("omg...
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 147750 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 632850 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 147750 | 0.320 |
22 | 742217 | 0.315 |
27 | 827188 | 0.310 |
11 | 272208 | 0.305 |
28 | 366102 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 632850 | 6 |
0.330 | 90273 | 5 |
0.335 | 193342 | 5 |
0.340 | 408713 | 7 |
0.345 | 406365 | 7 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online